NCT01718639View on ClinicalTrials.gov

Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn

PHASE4CompletedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Postprandial Heartburn

Interventions

DEVICE

IQP-LH-101 tablet

Oral medical device in the form of a chewable tablet

DEVICE

IQP-LH-101 liquid

Oral medical device in the form of a liquid

OTHER

Placebo

Trial Locations (1)

10369

Weißenseerweg 111, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

InQpharm Group

INDUSTRY